Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ioana-Cristina Bica"'
Autor:
Teodor Salmen, Claudia-Gabriela Potcovaru, Ioana-Cristina Bica, Rosaria Vincenza Giglio, Angelo Maria Patti, Roxana-Adriana Stoica, Marcello Ciaccio, Mohamed El-Tanani, Andrej Janež, Manfredi Rizzo, Florentina Gherghiceanu, Anca Pantea Stoian
Publikováno v:
Pharmaceuticals, Vol 17, Iss 10, p 1322 (2024)
Background This systematic review is registered with CRD42024507397 protocol number and aims to compare the known data about retatrutide on long-term cardiovascular (CV) protection with tirzepatide, an incretin with recent proven CV benefits. Materia
Externí odkaz:
https://doaj.org/article/9615117acb6a4894b4f7e72b5ff13791
Autor:
Teodor Salmen, Valeria-Anca Pietrosel, Delia Reurean-Pintilei, Mihaela Adela Iancu, Radu Cristian Cimpeanu, Ioana-Cristina Bica, Roxana-Ioana Dumitriu-Stan, Claudia-Gabriela Potcovaru, Bianca-Margareta Salmen, Camelia-Cristina Diaconu, Sanda Maria Cretoiu, Anca Pantea Stoian
Publikováno v:
Pharmaceuticals, Vol 17, Iss 9, p 1249 (2024)
Introduction: Type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) share a bidirectional link, and the innovative antidiabetic molecules GLP-1 Ras and SGLT-2is have proven cardiac and renal benefits, respectively. This study aimed to eval
Externí odkaz:
https://doaj.org/article/2fc12d459ff24c4a8199472ef312bd79
Autor:
Teodor Salmen, Ali Abbas Rizvi, Manfredi Rizzo, Valeria-Anca Pietrosel, Ioana-Cristina Bica, Cosmina Theodora Diaconu, Claudia Gabriela Potcovaru, Bianca-Margareta Salmen, Oana Andreia Coman, Anca Bobircă, Roxana-Adriana Stoica, Anca Pantea Stoian
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2455 (2023)
In this paper, we aim to evaluate the efficacy of antidiabetic cardioprotective molecules such as Sodium-Glucose Cotransporter-2 Inhibitors (SGLT-2i) and Glucagon-like Peptide 1 Receptor Agonists (GLP-1 RAs) when used with other glucose-lowering drug
Externí odkaz:
https://doaj.org/article/c26eb08d8c774548b3efe95dfad18a80
Autor:
Ioana-Cristina Bica, Roxana Adriana Stoica, Teodor Salmen, Andrej Janež, Špela Volčanšek, Djordje Popovic, Emir Muzurovic, Manfredi Rizzo, Anca Pantea Stoian
Publikováno v:
Medicina, Vol 59, Iss 6, p 1136 (2023)
Type 2 Diabetes Mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) are part of metabolic syndrome and share multiple causal associations. Both conditions have an alarmingly increasing incidence and lead to multiple complications, which hav
Externí odkaz:
https://doaj.org/article/b8fc835b38314dd39fc99e33f3aba093
Autor:
Teodor Salmen, Liviu-Ionut Serbanoiu, Ioana-Cristina Bica, Cristian Serafinceanu, Emir Muzurović, Andrej Janez, Stefan Busnatu, Maciej Banach, Ali Abbas Rizvi, Manfredi Rizzo, Anca Pantea Stoian
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 11, p 9760 (2023)
The increase in life expectancy without a decrease in the years lived without disability leads to the rise of the population aged over 65 years prone to polypharmacy. The novel antidiabetic drugs can improve this global therapeutic and health problem
Externí odkaz:
https://doaj.org/article/0ca866bd58d2475893592451a36c01a7
Autor:
Bianca-Margareta Salmen, Valeria-Anca Pietrosel, Cristiana-Elena Durdu, Teodor Salmen, Cosmina Theodora Diaconu, Ioana-Cristina Bica, Claudia Gabriela Potcovaru, Florentina Gherghiceanu, Roxana-Adriana Stoica, Anca Pantea Stoian
Publikováno v:
Biomedicines, Vol 11, Iss 5, p 1492 (2023)
The increasing prevalence of gestational diabetes mellitus (GDM) requires non-invasive and precise techniques for evaluating the predisposing risk factors such as visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT). According to PRISM
Externí odkaz:
https://doaj.org/article/e7a7a50143b24d38b954c7ec51411df1
Autor:
Ioana-Cristina Bica, Valeria-Anca Pietroșel, Teodor Salmen, Cosmina-Theodora Diaconu, Carmen Fierbinteanu Braticevici, Roxana-Adriana Stoica, Andra Iulia Suceveanu, Anca Pantea Stoian
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 8, p 7184 (2023)
As the pathophysiologic mechanisms of type 2 diabetes mellitus (T2DM) are discovered, there is a switch from glucocentric to a more comprehensive, patient-centered management. The holistic approach considers the interlink between T2DM and its complic
Externí odkaz:
https://doaj.org/article/82b4d181cbcf4c609a380748b898417c
Autor:
Teodor Salmen, Florin-Teodor Bobirca, Ioana-Cristina Bica, Doina-Andrada Mihai, Corina Pop, Anca Pantea Stoian
Publikováno v:
Life, Vol 13, Iss 3, p 839 (2023)
Aim: We evaluated the safety of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for their use with other glucose-lowering drugs and drugs for the treatment of type 2 diabetes mellitus (T2DM
Externí odkaz:
https://doaj.org/article/2b960db393434424b6a398732873e63b
Autor:
Roxana Adriana Stoica, Laura Carina Tribus, Raluca Ioana Marin, Tara David, Carmen Monica Preda, Ioana Cristina Bica, Cristian Serafinceanu
Publikováno v:
Frontiers in Clinical Diabetes and Healthcare. 4
Non-alcoholic fatty liver disease (NAFLD) has an important role in the pathogenesis of cardiovascular diseases in the population with diabetes and it is highly prevalent in end-stage renal disease (ESRD) patients. This case series describes NAFLD ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bade438fff10efa7a0d8fb656e65ee50
https://doi.org/10.3389/fcdhc.2023.1113666
https://doi.org/10.3389/fcdhc.2023.1113666
Autor:
Teodor Salmen, Valeria-Anca Pietroșel, Bianca-Margareta Mihai, Ioana Cristina Bica, Claudiu Teodorescu, Horia Păunescu, Oana Andreia Coman, Doina-Andrada Mihai, Anca Pantea Stoian
Publikováno v:
Biomedicines. 10(10)
The present study aimed to analyse the published data and to realize an update about the use and pathogenesis of the novel antidiabetic drugs, respectively, dipeptidyl peptidase-4 inhibitors (DPP-4i), glucagon-like peptide-1 receptor agonists (GLP-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0147600ba75bbda5b149b011d8570f11
https://pubmed.ncbi.nlm.nih.gov/36289885
https://pubmed.ncbi.nlm.nih.gov/36289885